A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
Placental malaria (PM) is a deadly syndrome most frequent and severe in first pregnancies. PM results from accumulation of Plasmodium falciparum-infected erythrocytes (IE) that express the surface antigen VAR2CSA and bind to chondroitin sulfate A (CSA) in the placenta. Women become PM-resistant over...
Main Authors: | Justin YA Doritchamou, Jonathan P Renn, Bethany Jenkins, Almahamoudou Mahamar, Alassane Dicko, Michal Fried, Patrick E Duffy |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2022-02-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/76264 |
Similar Items
-
Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes
by: Michal Fried, et al.
Published: (2018-03-01) -
Can complement fix placental malaria?
by: Justin Y. A. Doritchamou, et al.
Published: (2021-09-01) -
VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria
by: Alice Tomlinson, et al.
Published: (2021-02-01) -
Doesn’t It All Come Down to Function? How To Correlate VAR2CSA Antibodies with Protection
by: Sedami Gnidehou, et al.
Published: (2020-06-01) -
NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131
by: Chmielewska SJ, et al.
Published: (2020-09-01)